Obesity: an endocrine tumor?

Area of Science:

• Endocrinology
• Oncology
• Metabolic Disorders

Background:

• Obesity prevalence has surged over 60% since 1990, becoming a major clinical challenge.
• Adipose tissue functions as an endocrine organ, releasing adipokines like leptin and adiponectin.
• Existing treatments for obesity often yield suboptimal results, necessitating novel therapeutic strategies.

Purpose of the Study:

• To explore the hypothesis that obesity can be conceptualized as an endocrine tumor.
• To analyze the genetic underpinnings, adipocyte proliferation, and neovascularization in obesity.
• To evaluate the potential of novel therapeutic approaches inspired by cancer treatment.

Main Methods:

• Review of existing literature on obesity, adipocyte biology, and tumor development.
• Comparative analysis of characteristics shared between obesity and endocrine tumors, including genetic basis and angiogenesis.
• Exploration of potential therapeutic parallels, such as "cytoreductive surgery" and anti-neoplastic agents.

Main Results:

• Obesity shares similarities with endocrine tumors, including genetic predisposition, adipocyte hyperplasia/hypertrophy, and neovascularization.
• Surgical removal of excess adipose tissue (liposuction) demonstrates beneficial metabolic effects, akin to tumor debulking.
• The endocrine tumor hypothesis provides a new framework for understanding and potentially treating obesity.

Conclusions:

• Viewing obesity as an endocrine tumor offers a novel paradigm for its management.
• Liposuction may be considered a form of "cytoreductive surgery" for obesity.
• Future obesity treatments could incorporate anti-angiogenic therapies and anti-neoplastic drugs.